Valley National Advisers Inc Alaunos Therapeutics, Inc. Transaction History

Valley National Advisers Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$3.95 - $5.35 $39,500 - $53,500	-10,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $41,300 - $69,400	10,000 New	10,000 $43,000
Q4 2017 Feb 13, 2018	SELL	$4.0 - $6.54 $400 - $654	-100 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $499 - $657	100	100 $1,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.